Dr. Janakiraman Subramanian
Claim this profileSaint Luke's Hospital of Kansas City
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
10 reported clinical trials
20 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
Stage III
Stage II
2Lung Cancer
Stage IV
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Janakiraman Subramanian is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
More about Janakiraman Subramanian
Clinical Trial Related5 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Janakiraman Subramanian has experience with
- Carboplatin
- Pemetrexed
- Pembrolizumab
- Pemetrexed Disodium
- Gemcitabine Hydrochloride
- NovoTTF-200T
Breakdown of trials Janakiraman Subramanian has run
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Lung Adenocarcinoma
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Janakiraman Subramanian specialize in?
Janakiraman Subramanian focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Janakiraman Subramanian currently recruiting for clinical trials?
Yes, Janakiraman Subramanian is currently recruiting for 5 clinical trials in Kansas City Missouri. If you're interested in participating, you should apply.
Are there any treatments that Janakiraman Subramanian has studied deeply?
Yes, Janakiraman Subramanian has studied treatments such as Carboplatin, Pemetrexed, Pembrolizumab.
What is the best way to schedule an appointment with Janakiraman Subramanian?
Apply for one of the trials that Janakiraman Subramanian is conducting.
What is the office address of Janakiraman Subramanian?
The office of Janakiraman Subramanian is located at: Saint Luke's Hospital of Kansas City, Kansas City, Missouri 64111 United States. This is the address for their practice at the Saint Luke's Hospital of Kansas City.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.